Cosmo Pharmaceuticals
C43.F
#5450
Rank
$1.02 B
Marketcap
$63.85
Share price
0.00%
Change (1 day)
-14.43%
Change (1 year)

Revenue for Cosmo Pharmaceuticals (C43.F)

Revenue in 2023: $0.10 Billion USD

According to Cosmo Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is $0.10 Billion USD. In 2023 the company made a revenue of $0.10 Billion USD a decrease over the revenue in the year 2022 that were of $0.10 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cosmo Pharmaceuticals from 2004 to 2023

Annual revenue

Year Revenue Change
2023$0.10 B-6.34%
2022$0.10 B48.59%
2021$73.69 M-1.69%
2020$74.96 M7.08%
2019$70 M-6.74%
2018$75.06 M-6.96%
2017$80.68 M13.36%
2016$71.17 M7.4%
2015$66.26 M-31.54%
2014$96.8 M24.35%
2013$77.84 M-1.15%
2012$78.75 M80.97%
2011$43.51 M2.08%
2010$42.63 M11.51%
2009$38.23 M-19.97%
2008$47.77 M49.4%
2007$31.97 M59.87%
2006$20 M8.89%
2005$18.36 M22.77%
2004$14.96 M